Curevac and Novavax start phase III COVID-19 clinical trials in Mexico

MEXICO CITY (Latinus) – Mexico’s foreign minister Marcelo Ebrard said on Friday that CureVac and.

Novavax starts Phase 3 COVID vaccine trial with 30,000 volunteers in the U.S. and Mexico

Novavax Inc. NVAX, -3.16% declared on Monday, December 28th, it is starting a late-stage trial of its COVID-19.

On phase 1, data shows Novavax coronavirus vaccine is safe and elicits an immune response

A third US company has released study results showing its coronavirus vaccine is safe and.

Title

Red Tide affecting tourism in Progreso and other ports

The president of the local delegation of the National Chamber of Small-scale Commerce (CANACOPE), Jorge Cardeña Licona, declared that the…

7 new cases of monkeypox detected in Yucatan

According to information provided by the Yucatan health secretary, there are 7 new cases of monkeypox detected in the last…

The federal government starts construction of the new Yucatan thermoelectric plant

The construction of the thermoelectric plant, announced by the federal government on several occasions, has already begun with the leveling…

System in the Gulf of Mexico has small chance to develop into tropical depression

The National Hurricane Center continues to keep its eye on a system in the Gulf of Mexico with a small…

61% of the total indigenous-speaking population is concentrated in 5 states

Only five states concentrate more than 61.09 percent of the population that speaks indigenous languages Yucatán, Oaxaca, Chiapas, Veracruz and…